Drugs / The pleiotropic factor derived from mesenchymal stem cells
The pleiotropic factor derived from mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04538885 | Sep 2020 → Mar 2021 | — | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | The pleiotropic factor derived from mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04538885 ↗ |
| Route | Topical | “The pleiotropic factor derived from mesenchymal stem cells was smeared on the wound” NCT04538885 ↗ |